Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Carevive SMART Data – EVALUATE

Through the Carevive digital oncology platform, utilized by cancer centers across the US, we gather patient experience data directly from those battling breast cancer, lung cancer, multiple myeloma, ovarian cancer, and AML. This data collection aims to address three crucial questions: Firstly, the feasibility of gathering real-world patient experience data in routine care settings. Secondly,…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Carevive on MarketScale.

Share
Carevive SMART Data – EVALUATE

Get featured

Want MarketScale to feature Healthcare?

Book a 15-minute demo and we'll map your Healthcare expertise to the content buyers are searching for.

Book a demo

Through the Carevive digital oncology platform, utilized by cancer centers across the US, we gather patient experience data directly from those battling breast cancer, lung cancer, multiple myeloma, ovarian cancer, and AML. This data collection aims to address three crucial questions: Firstly, the feasibility of gathering real-world patient experience data in routine care settings. Secondly, the invaluable trends that longitudinal real-world data sets can reveal about the patient experience. Lastly, how digital tools empower clinicians to predict and manage the experiences of cancer patients more effectively.

With a comprehensive approach, Carevive is transforming cancer care by harnessing the power of patient experience insights. Join us on this transformative journey as we continue to make a positive impact on the lives of cancer patients and their healthcare providers. Together, we build a brighter future for cancer care, one step at a time.

Carevive

Part of this channel

Carevive

Remote oncology monitoring that connects clinicians and cancer patients between visits.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

The Centers for Medicare & Medicaid Services (CMS) launched its tech-enabled chronic care pilot program, known as the ACCESS pilot. Despite its initiation, a significant issue persists as patients struggle to find which healthcare providers are participating in the program. Meanwhile, the FDA has authorized 115 AI-based medical devices in 2021.

  • 01CMS has initiated the ACCESS pilot program to enhance chronic care management using technology.
  • 02Patients are facing challenges in identifying healthcare providers involved in the ACCESS pilot.
  • 03In 2021, the FDA authorized 115 AI-based medical devices.

Aug 17, 2026

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

BioNTech has appointed Guido Oelkers, the current CEO of Sobi, as its next chief executive. Oelkers is tasked with advancing BioNTech's oncology pipeline to achieve multiple approved products by 2030.

  • 01BioNTech has selected Guido Oelkers as its new CEO, effective soon.
  • 02Guido Oelkers aims to turn BioNTech's deep oncology pipeline into several approved products by 2030.

Aug 17, 2026

Health systems are spending big on EHRs and AI while governance gaps widen

Health systems are spending big on EHRs and AI while governance gaps widen

Health systems are investing heavily in electronic health records (EHRs) and artificial intelligence (AI). However, there are notable governance gaps in AI implementation in hospitals. Many hospitals lack dedicated platforms for AI testing and reimbursement issues for AI remain unresolved.

  • 01Health systems are making significant financial investments in electronic health records and AI technology.
  • 02AI reimbursement policies remain unclear, posing challenges for healthcare providers.
  • 03Most hospitals do not have dedicated platforms for testing AI applications.

Aug 17, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512